Acceleration of Cancer Therapeutic Tolerance Test Conversion Project for exploitation via spinout TestaVec
Funder: Engineering and Physical Sciences Research CouncilDuration: January 2024 - March 2024
Development of diagnostics
People
| Name | Telephone | Office | ||
|---|---|---|---|---|
|
Professor Michael Themis Professor - Gene Therapy and Genotoxicity (Principal investigator)
T: +44 (0)1895 267252
E: michael.themis@brunel.ac.uk |
+44 (0)1895 267252 | michael.themis@brunel.ac.uk | Heinz Wolff 235 |